Sunday - November 9, 2025
GSK Presents Data From Its Advancing Liver Pipeline at AASLD 2025
November 08, 2025
LONDON, England, Nov. 8 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK presents data from its advancing liver pipeline at AASLD 2025

* 21 abstracts highlight advances in the treatment of liver conditions, building from GSK's expertise in inflammation and fibrosis

* Phase II B-Sure study sub-analysis shows durability of functional cure in chronic hepatitis B (CHB) patients treate . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products